Glenmark Pharma rises 2% as Nomura maintains buy, hike target to Rs 850
At 11:38 hrs Glenmark Pharma was quoting at Rs 656.40, up Rs 3, or 0.46 percent on the BSE.
The share touched its 52-week high Rs 711.55 and 52-week low Rs 483.60 on 10 September, 2018 and 30 May, 2018, respectively.
Currently, it is trading 7.75 percent below its 52-week high and 35.73 percent above its 52-week low.